Trial Profile
A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Indinavir (Primary) ; Cancer vaccine; Influenza virus vaccines; Interleukin-2
- Indications CNS cancer; Ewing's sarcoma; Influenza virus infections; Neuroectodermal tumours; Neuroepithelial neoplasms; Rhabdomyosarcoma
- Focus Therapeutic Use
- 11 Jun 2012 Primary endpoints added as reported by ClinicalTrials.gov.
- 22 Nov 2011 New trial record